AU509651B2 - Thiazolidine derivatives - Google Patents

Thiazolidine derivatives

Info

Publication number
AU509651B2
AU509651B2 AU28657/77A AU2865777A AU509651B2 AU 509651 B2 AU509651 B2 AU 509651B2 AU 28657/77 A AU28657/77 A AU 28657/77A AU 2865777 A AU2865777 A AU 2865777A AU 509651 B2 AU509651 B2 AU 509651B2
Authority
AU
Australia
Prior art keywords
thiazolidine derivatives
thiazolidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU28657/77A
Other languages
English (en)
Other versions
AU2865777A (en
Inventor
B. Lang H-J and Glanzer E Knabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU2865777A publication Critical patent/AU2865777A/en
Application granted granted Critical
Publication of AU509651B2 publication Critical patent/AU509651B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84Naphthothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU28657/77A 1976-09-08 1977-09-08 Thiazolidine derivatives Expired AU509651B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762640358 DE2640358A1 (de) 1976-09-08 1976-09-08 Thiazolidinderivate und verfahren zu ihrer herstellung
DEDE2640358 1976-09-08

Publications (2)

Publication Number Publication Date
AU2865777A AU2865777A (en) 1979-03-15
AU509651B2 true AU509651B2 (en) 1980-05-22

Family

ID=5987411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28657/77A Expired AU509651B2 (en) 1976-09-08 1977-09-08 Thiazolidine derivatives

Country Status (20)

Country Link
US (1) US4174397A (US06168776-20010102-C00028.png)
JP (1) JPS5334771A (US06168776-20010102-C00028.png)
AT (2) AT365181B (US06168776-20010102-C00028.png)
AU (1) AU509651B2 (US06168776-20010102-C00028.png)
BE (1) BE858520A (US06168776-20010102-C00028.png)
CA (1) CA1089458A (US06168776-20010102-C00028.png)
DE (1) DE2640358A1 (US06168776-20010102-C00028.png)
DK (1) DK397777A (US06168776-20010102-C00028.png)
ES (1) ES462065A1 (US06168776-20010102-C00028.png)
FI (1) FI772642A (US06168776-20010102-C00028.png)
FR (1) FR2364219A1 (US06168776-20010102-C00028.png)
GB (1) GB1592272A (US06168776-20010102-C00028.png)
HU (1) HU175751B (US06168776-20010102-C00028.png)
IT (1) IT1084414B (US06168776-20010102-C00028.png)
NL (1) NL7709697A (US06168776-20010102-C00028.png)
NO (1) NO773094L (US06168776-20010102-C00028.png)
NZ (1) NZ185105A (US06168776-20010102-C00028.png)
PT (1) PT67014B (US06168776-20010102-C00028.png)
SE (1) SE7710084L (US06168776-20010102-C00028.png)
ZA (1) ZA775405B (US06168776-20010102-C00028.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59210039A (ja) * 1983-05-16 1984-11-28 Kirin Brewery Co Ltd 2−ブロモ−1−テトラロン誘導体およびその用途
JPS6297769A (ja) * 1985-10-23 1987-05-07 Kobe Steel Ltd 溶接管の製造方法
MY106964A (en) * 1988-04-28 1995-08-30 Schering Corp Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
DE19736922A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Halogenindan-1-onen
DE19736921A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Cyanoindan-1-onen
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908533A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908536A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2001032638A1 (de) * 1999-11-05 2001-05-10 Aventis Pharma Deutschland Gmbh Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1259498B1 (de) * 2000-02-23 2004-11-24 Aventis Pharma Deutschland GmbH 8,8a-dihydro-indeno [1,2-d]thiazol-derivate, die in 8a-stellung substituiert sind, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel z.b. als anorektika
AU2001244136B2 (en) * 2000-02-26 2005-04-14 Sanofi-Aventis Deutschland Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, method for production thereof and use thereof as medicament
DE10142661B4 (de) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142722A1 (de) 2001-08-31 2003-03-27 Aventis Pharma Gmbh C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
JP6204583B2 (ja) * 2014-05-15 2017-09-27 富士フイルム株式会社 α−ブロモアセトフェノン化合物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT67014A (de) 1977-09-30
AU2865777A (en) 1979-03-15
GB1592272A (en) 1981-07-01
DK397777A (da) 1978-03-09
CA1089458A (en) 1980-11-11
FR2364219B1 (US06168776-20010102-C00028.png) 1980-06-20
IT1084414B (it) 1985-05-25
BE858520A (fr) 1978-03-08
FI772642A (fi) 1978-03-09
NO773094L (no) 1978-03-09
ATA171881A (de) 1984-01-15
DE2640358A1 (de) 1978-03-16
NL7709697A (nl) 1978-03-10
SE7710084L (sv) 1978-03-09
ES462065A1 (es) 1978-06-01
PT67014B (de) 1979-05-14
ATA643577A (de) 1981-05-15
ZA775405B (en) 1978-07-26
AT365181B (de) 1981-12-28
FR2364219A1 (fr) 1978-04-07
NZ185105A (en) 1979-12-11
JPS5334771A (en) 1978-03-31
US4174397A (en) 1979-11-13
HU175751B (hu) 1980-10-28

Similar Documents

Publication Publication Date Title
AU509754B2 (en) Benazepine derivatives
AU509651B2 (en) Thiazolidine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU511547B2 (en) Thiazolidine derivatives
AU504526B2 (en) Pipeazine derivatives
AU509570B2 (en) Thiourea derivatives
AU517829B2 (en) Morphanthridine derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU512647B2 (en) Solpenamide derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU2134277A (en) Thiazolidine derivatives
AU2888077A (en) Thiazolidines
AU505150B2 (en) Triazolobenzazepine derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU538794B2 (en) Thiazole derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU515135B2 (en) Ribofuranosyl-imidazole derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives
AU540464B2 (en) Morphanthridine derivatives